FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sarah Taylor

Research Profile

Activities & Behaviors

Drug Evaluation

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Heather Male; Amy R O'Brien-Ladner; Vijay Patel; Ossama Tawfik; Sarah A Taylor; Peter Van Veldhuizen; Kun Wang; Stephen K Williamson; Amanda L Wise; Derek A Young; Emma Borrego-Diaz; Tuba Esfandyari; Chao Huang; Mark A Jacob; Faris Farassati
Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer.
Ashok K Malani; Rony M Abou-Jawde; Jaswinder Singh; Sarah A Taylor
Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients.
Martin J Edelman; Kari Chansky; Laurie E Gaspar; Bryan R Leigh; Geoffrey R Weiss; Sarah A Taylor; John Crowley; Robert Livingston; David R Gandara
Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sarah Taylor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Heather Male; Amy R O'Brien-Ladner; Vijay Patel; Ossama Tawfik; Sarah A Taylor; Peter Van Veldhuizen; Kun Wang; Stephen K Williamson; Amanda L Wise; Derek A Young; Emma Borrego-Diaz; Tuba Esfandyari; Chao Huang; Mark A Jacob; Faris Farassati
Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2012;77(2):252-9.
2007: Ashok K Malani; Rony M Abou-Jawde; Jaswinder Singh; Sarah A Taylor
Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1143-4; author reply 1144.
2004: Martin J Edelman; Kari Chansky; Laurie E Gaspar; Bryan R Leigh; Geoffrey R Weiss; Sarah A Taylor; John Crowley; Robert Livingston; David R Gandara
Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):127-32.
2003: Douglas W Blayney; Michael L LeBlanc; Thomas M Grogan; Ellen R Gaynor; Robert A Chapman; C Harris Spiridonidis; Sarah A Taylor; Scott I Bearman; Thomas P Miller; Richard I Fisher
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2466-73.
2003: Maurie Markman; Tracy Glass; Harriet O Smith; Kenneth D Hatch; Geoffrey R Weiss; Sarah A Taylor; J Wendall Goodwin; David S Alberts
Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial.
Gynecologic oncology 2003;88(3):282-8.
2002: Sarah A Taylor; Cathryn Rankin; Jeannette J Townsend; Johnny B Craig; Ralph B Vance; Dilip L Solank; Thomas D Brown; Kurt A Jaeckle
Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group study.
Investigational new drugs 2002;20(1):113-5.
2001: Charles Thomas; Dorothy J Giroux; L M Janaki; A T Turrisi; John J Crowley; Sarah A Taylor; J D McCracken; P G Shankir Giri; W Gordon; Robert B Livingston; David R Gandara
Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;33(2-3):213-9.
2001: Karen Kelly; L Lovato; Paul A Bunn; Robert B Livingston; J Zangmeister; Sarah A Taylor; D Roychowdhury; J J Crowley; David R Gandara
Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2325-9.
2001: Robert P Whitehead; Joseph M Unger; Lawrence E Flaherty; J R Eckardt; Sarah A Taylor; MUKUND DIDOLKAR; Wolfram E Samlowski; vernon sondak
Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy. A Southwest Oncology Group study.
Investigational new drugs 2001;19(3):239-43.
2000: John S Macdonald; J L Jacobson; S J Ketchel; G Weiss; Sarah A Taylor; G Mills; J P Kuebler; S Rivkin; M Conrad
A phase II trial of topotecan in esophageal carcinoma: a Southwest Oncology Group study (SWOG 9339).
Investigational new drugs 2000;18(2):199-202.
1999: Georgiana K Ellis; S Green; Robert B Livingston; M J Kraut; HI Pierce; J C Paradelo; Sarah A Taylor; S Martino
'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast cancer: a Southwest Oncology Group Phase II Study.
American journal of clinical oncology 1999;22(5):446-9.
1999: vernon sondak; PY Liu; Lawrence E Flaherty; WS Fletcher; P Periman; David R Gandara; Sarah A Taylor; S P Balcerzak; F L Meyskens
A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study.
The cancer journal from Scientific American 1999;5(1):41-7.
1998: Antoinette J Wozniak; John J Crowley; Stanley P Balcerzak; Geoffrey R Weiss; C Harris Spiridonidis; Laurence H Baker; Kathy S Albain; Karen Kelly; Sarah A Taylor; David R Gandara; Robert B Livingston
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2459-65.
1998: Charles Thomas; Dorothy J Giroux; Keith J Stelzer; J B Craig; L R Laufman; Sarah A Taylor; J Wendall Goodwin; John J Crowley; Robert B Livingston
Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
International journal of radiation oncology, biology, physics 1998;40(5):1039-47.
1998: Sydney E Salmon; John J Crowley; S P Balcerzak; R W Roach; Sarah A Taylor; Saul E Rivkin; Wolfram E Samlowski
Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):890-6.
1998: E H Kraut; J J Crowley; James L Wade Iii; L R Laufman; M Alsina; Sarah A Taylor; S E Salmon
Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):589-92.
1998: Sarah A Taylor; Dorothy J Giroux; Kurt A Jaeckle; T J Panella; Shaker R Dakhil; S Clifford Schold
Phase II study of Didemnin B in central nervous system tumors: a Southwest Oncology Group study.
Investigational new drugs 1998;16(4):331-2.
1997: Robert P Whitehead; J Jacobson; T D Brown; Sarah A Taylor; Geoffrey R Weiss; John S Macdonald
Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2414-9.
1996: P J Van Veldhuizen; Sarah A Taylor
Chylothorax: a complication of a left subclavian vein thrombosis.
American journal of clinical oncology 1996;19(2):99-101.
1996: R E Smith; D Lew; G I Rodriguez; Sarah A Taylor; D Schuller; John F Ensley
Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck. A phase II Southwest Oncology Group study.
Investigational new drugs 1996;14(4):403-7.
1995: W T Sause; C Scott; Sarah A Taylor; D Johnson; R Livingston; R Komaki; B Emami; Walter Curran; Roger W. Byhardt; A T Turrisi
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
Journal of the National Cancer Institute 1995;87(3):198-205.
1994: Ronald M Bukowski; C M Tangen; R F Peterson; Sarah A Taylor; J J Rinehart; H J Eyre; S E Rivkin; T R Fleming; J S Macdonald
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study.
Cancer 1994;73(5):1505-8.
1994: Sarah A Taylor; B A Blumenstein; R L Stephens; E D Crawford; B Pistone; J B Hill
Phase II trial of menogaril in metastatic adenocarcinoma of the prostate. A Southwest Oncology Group study.
Investigational new drugs 1994;12(1):67-70.
1994: Sarah A Taylor
New agents in the treatment of primary brain tumors.
Journal of neuro-oncology 1994;20(2):141-53.
1994: Michael R Grever; J Benedetti; S P Balcerzak; Sarah A Taylor; T P Miller; S R Dakhil
A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma.
Investigational new drugs 1994;12(3):259-61.
1993: Sarah A Taylor; J Benedetti; D Schuller; Stephen Richman; G O Broun; A Hantel
Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trial.
Investigational new drugs 1993;11(2-3):227-9.
1993: Sarah A Taylor; J Crowley; J Townsend; F S Vogel; H Eyre; J J Braun; J Wendall Goodwin
Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies. A Southwest Oncology Group study.
Journal of neuro-oncology 1993;15(2):181-4.
1993: Ronald M Bukowski; T R Fleming; J S Macdonald; N Oishi; Sarah A Taylor; Laurence H Baker
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study.
Cancer 1993;71(2):322-5.
1992: Sarah A Taylor; P Goodman; E D Crawford; W J Stuckey; R L Stephens; E R Gaynor
Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney. A Southwest Oncology Group study.
Investigational new drugs 1992;10(1):55-6.
1992: William T Sause; C Scott; Sarah A Taylor; Roger W. Byhardt; F L Banker; J W Thomson; T K Jones; Jay S Cooper; R D Lindberg
Phase II trial of combination chemotherapy and irradiation in non-small-cell lung cancer, Radiation Therapy Oncology Group 88-04.
American journal of clinical oncology 1992;15(2):163-7.
1991: T D Brown; P J Goodman; T Fleming; J S Macdonald; T O'Rourke; Sarah A Taylor; J R Neefe; E Gaynor
Phase II trial of recombinant DNA gamma-interferon in advanced colorectal cancer: a Southwest Oncology Group study.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(5):379-82.
1991: Sarah A Taylor; J Crowley; T W Pollock; H J Eyre; C Jaeckle; H E Hynes; R L Stephens
Objective antitumor activity of acivicin in patients with recurrent CNS malignancies: a Southwest Oncology Group trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1476-9.
1991: Sarah A Taylor; J Crowley; F S Vogel; J J Townsend; H J Eyre; Kurt A Jaeckle; H E Hynes; J T Guy
Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors. A Southwest Oncology Group trial.
Investigational new drugs 1991;9(2):195-7.
1991: J M Wyrick; L O Niemeyer; M Ellexson; K Jacobs; Sarah A Taylor
Occupational therapy work-hardening programs: a demographic study.
The American journal of occupational therapy : official publication of the American Occupational Therapy Association 1991;45(2):109-12.
1991: T D Brown; P J Goodman; T R Fleming; Sarah A Taylor; J S Macdonald
Phase II trial of echinomycin in advanced colorectal cancer. A Southwest Oncology Group study.
Investigational new drugs 1991;9(1):113-4.
1990: Charles W Taylor; J Crowley; S K Williamson; Thomas P Miller; Sarah A Taylor; T G Giri; R L Stephens; R B Livingston
Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(11):1811-7.
1990: Sarah A Taylor; B Metch; Stanley P Balcerzak; K H Hanson
Phase II trial of echinomycin in advanced soft tissue sarcomas. A Southwest Oncology Group study.
Investigational new drugs 1990;8(4):381-3.
1990: J D McCracken; L M Janaki; J J Crowley; Sarah A Taylor; P G Giri; G B Weiss; W Gordon; Laurence H Baker; A Mansouri; J P Kuebler
Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):892-8.
1990: Sarah A Taylor; T Fleming; Daniel Von Hoff; J D McCracken; R M Bukowski; R W Talley; R B Natale; J T Guy; W E Samlowski; J H Costanzi
Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group study.
Investigational new drugs 1990;8(1):77-80.
1990: W A Knight; P Goodman; Sarah A Taylor; J S Macdonald; C A Coltman; J J Constanzi; Laurence H Baker
Phase II trial of intravenous melphalan for metastatic colorectal carcinoma. A Southwest Oncology Group study.
Investigational new drugs 1990;8 Suppl 1():S87-9.
1988: W T Sause; J Crowley; H J Eyre; S E Rivkin; R P Pugh; J M Quagliana; Sarah A Taylor; B Molnar
Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases--a Southwest Oncology Group study.
Journal of neuro-oncology 1988;6(2):107-12.
1987: S K Williamson; Sarah A Taylor
Phase I trial of aggressive weekly chemotherapy in small-cell carcinoma of the lung.
American journal of clinical oncology 1987;10(6):496-8.
1987: G B Weiss; B Metch; Daniel Von Hoff; Sarah A Taylor; J H Saiers
Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study.
Cancer treatment reports 1987;71(12):1313-4.
1987: P G Shankar Giri; Sarah A Taylor
Concurrent chemotherapy and radiation therapy in advanced head and neck cancer.
American journal of clinical oncology 1987;10(5):417-21.
1986: G R Weiss; J Crowley; Daniel Von Hoff; Sarah A Taylor; R J Belt; C A Coltman; H E Hynes; J J Costanzi
Phase II study of fludarabine phosphate for the treatment of advanced non-small cell carcinoma of the lung: a Southwest Oncology Group Study.
Cancer treatment reports 1986;70(9):1123-4.
1986: F J Panettiere; S E Jones; N Oishi; H J Eyre; R M O'Bryan; W A Andes; Sarah A Taylor; P N Grozea
Bisantrene hydrochloride in gastric adenocarcinoma: a Southwest Oncology Group Study.
Medical and pediatric oncology 1986;14(2):78-80.
1985: J P McGovren; E A Pratt; R J Belt; Sarah A Taylor; R S Benjamin; Bach Ardalan; T Ohnuma
Pharmacokinetic and biochemical studies on acivicin in phase I clinical trials.
Cancer research 1985;45(9):4460-3.
1985: Sarah A Taylor; B T Tranum; Daniel Von Hoff; J J Costanzi
Phase II trial of 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino 9,10-anthracenedione dihydrochloride)(NSC 301739, DHAD) in patients with metastatic malignant melanoma. A Southwest Oncology Group pilot.
Investigational new drugs 1985;3(1):67-9.
1985: W J Moriconi; Sarah A Taylor; M Slavik; R J Belt; C D Haas; B Hoogstraten
Phase I evaluation of chlorozotocin (NSC-178248): weekly schedule.
Investigational new drugs 1985;3(1):57-62.
1985: Sarah A Taylor; J D McCracken; H J Eyre; R M O'Bryan; B A Neilan
Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study.
Journal of neuro-oncology 1985;3(2):131-5.
1984: Sarah A Taylor; Daniel Von Hoff; Laurence H Baker; S P Balcerzak
Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Cancer treatment reports 1984;68(6):919-20.
1980: Sarah A Taylor; R J Belt; C D Haas; R L Stephens; B Hoogstraten
Phase I evaluation of chlorozotocin: single dose every six weeks.
Cancer 1980;46(11):2365-8.